Cancer immunotherapy activates CD8+ T lymphocytes, which primarily use the perforin-granzyme and Fas/Fas-ligand-pathways to cause tumour cell apoptosis (Nowak et al., 2003; Wang et al., 2019). The gene discussed is FAS; the disease is cancer.